These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 23233709)
1. EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis. Alifrangis C; Agarwal R; Short D; Fisher RA; Sebire NJ; Harvey R; Savage PM; Seckl MJ J Clin Oncol; 2013 Jan; 31(2):280-6. PubMed ID: 23233709 [TBL] [Abstract][Full Text] [Related]
2. Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia. Even C; Pautier P; Duvillard P; Floquet A; Kerbrat P; Troalen F; Rey A; Balleyguier C; Tazi Y; Leary A; Augereau P; Morice P; Droz JP; Fizazi K; Lhommé C Eur J Cancer; 2014 Aug; 50(12):2082-9. PubMed ID: 24910417 [TBL] [Abstract][Full Text] [Related]
3. Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia. Lybol C; Thomas CM; Blanken EA; Sweep FC; Verheijen RH; Westermann AM; Boere IA; Reyners AK; Massuger LF; van Hoesel RQ; Ottevanger PB Eur J Cancer; 2013 Mar; 49(4):860-7. PubMed ID: 23099004 [TBL] [Abstract][Full Text] [Related]
4. [EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia]. Shen T; Chen LL; Qin JL; Wang XY; Cheng XD; Xie X; Lyu WG Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):371-376. PubMed ID: 29961278 [No Abstract] [Full Text] [Related]
5. Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia. Lurain JR; Schink JC J Reprod Med; 2012; 57(5-6):219-24. PubMed ID: 22696816 [TBL] [Abstract][Full Text] [Related]
6. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia]. Song SQ; Zhang GN Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175 [TBL] [Abstract][Full Text] [Related]
7. Outcome of gestational trophoblastic neoplasia: experience from a tertiary cancer centre in India. Gulia S; Bajpai J; Gupta S; Maheshwari A; Deodhar K; Kerkar RA; Seth V; Rekhi B; Menon S Clin Oncol (R Coll Radiol); 2014 Jan; 26(1):39-44. PubMed ID: 24051171 [TBL] [Abstract][Full Text] [Related]
8. Treatment of high-risk gestational trophoblastic neoplasia with weekly high-dose methotrexate-etoposide. Han SN; Amant F; Leunen K; Devi UK; Neven P; Berteloot P; Vergote I Gynecol Oncol; 2012 Oct; 127(1):47-50. PubMed ID: 22705360 [TBL] [Abstract][Full Text] [Related]
9. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528 [TBL] [Abstract][Full Text] [Related]
10. Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen. Mao Y; Wan X; Lv W; Xie X Int J Gynaecol Obstet; 2007 Jul; 98(1):44-7. PubMed ID: 17481633 [TBL] [Abstract][Full Text] [Related]
11. Clinical epidemiology and management of gestational trophoblastic neoplasia in Hungary in the past 34 years. Fülöp V; Szigetvári I; Szepesi J; Végh G; Singh M; Berkowitz RS J Reprod Med; 2012; 57(7-8):310-8. PubMed ID: 22838247 [TBL] [Abstract][Full Text] [Related]
12. Management of drug resistant gestational trophoblastic neoplasia. Patel SM; Desai A J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341 [TBL] [Abstract][Full Text] [Related]
16. Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy. Escobar PF; Lurain JR; Singh DK; Bozorgi K; Fishman DA Gynecol Oncol; 2003 Dec; 91(3):552-7. PubMed ID: 14675675 [TBL] [Abstract][Full Text] [Related]
17. Effects of single-agent and combination chemotherapy for gestational trophoblastic tumors on risks of second malignancy and early menopause. Savage P; Cooke R; O'Nions J; Krell J; Kwan A; Camarata M; Dancy G; Short D; Seckl MJ; Swerdlow A J Clin Oncol; 2015 Feb; 33(5):472-8. PubMed ID: 25547507 [TBL] [Abstract][Full Text] [Related]
18. [Impact of chemotherapy on ovarian function and quality of life of patients with gestational trophoblastic neoplasia]. Xue W; Yang JJ; Zhao J; Ren T; Feng FZ; Wan XR; Xiang Y Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):377-383. PubMed ID: 29961279 [No Abstract] [Full Text] [Related]
20. Changes in the management of high-risk gestational trophoblastic neoplasia in the National Trophoblastic Disease Center of Hungary. Fülöp V; Szigetvári I; Szepesi J; Végh G; Berkowitz RS J Reprod Med; 2014; 59(5-6):227-34. PubMed ID: 24937962 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]